{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:32:23Z","timestamp":1793705543867,"version":"4.5.1"},"reference-count":142,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2514527","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:06:33Z","timestamp":1749791193000},"page":"556-569","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3577-8969","authenticated-orcid":false,"given":"Giacomo","family":"Casabona","sequence":"first","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-3744","authenticated-orcid":false,"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-4923","authenticated-orcid":false,"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health","place":["Cogorno, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8414-1657","authenticated-orcid":false,"given":"Volker","family":"Vetter","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5292-3630","authenticated-orcid":false,"given":"Maurine","family":"Duchenne","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-307X","authenticated-orcid":false,"given":"Raunak","family":"Parikh","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801005921"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/v10110609"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.055"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02534-7"},{"key":"e_1_3_7_8_1","unstructured":"Lopez A Harrington T Marin M [Internet]. Pinkbook: varicella. 2021 [cited 2024 Nov 5. Available from: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-22-varicella.html"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.57187\/s.3962"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00899-7"},{"key":"e_1_3_7_11_1","unstructured":"UK Health Security Agency [Internet]. DH green book chapter 28a - shingles. 2024 [cited 2024 Nov 5]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/6603fedef9ab41001aeea371\/Shingles_Green_Book_chapter_28a_20240315.pdf"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800106"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.06.016"},{"key":"e_1_3_7_15_1","volume-title":"DH Green book chapter 34 - varicella","author":"UK Health Security Agency","year":"2024","unstructured":"UK Health Security Agency. DH Green book chapter 34 - varicella. The Stationery Office; 2024 [cited 2024 Nov 5]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/66faaaf2a31f45a9c765eeb1\/Green-book-Chapter-34-Varicella_25_9_24.pdf"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1394843"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27538"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.10.006"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2445-2"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1573145"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1343669"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2266225"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e3182510b67"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.02983.x"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03705.x"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/2333794X14567194"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12343-x"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-024-05763-5"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.05.008"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900233"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068611"},{"key":"e_1_3_7_33_1","unstructured":"NHS Health Research Authority [Internet]. Quality of life effects of chickenpox on hospitalised children. 2018 [cited 2024 Nov 5]. Available from: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/quality-of-life-effects-of-chickenpox-on-hospitalised-children\/"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615599151"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-011-0481-8"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2278-z"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1985890"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/655136"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad137"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08800-x"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.088064"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03201-5"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3415"},{"issue":"108","key":"e_1_3_7_45_1","first-page":"71","article-title":"How to manage herpes zoster ophthalmicus","volume":"33","author":"Tuft S","year":"2020","unstructured":"Tuft S. How to manage herpes zoster ophthalmicus. CEHJ. 2020;33(108):71\u201372.","journal-title":"CEHJ"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00990-7"},{"key":"e_1_3_7_47_1","volume-title":"Herpes zoster ophthalmicus treasure island","author":"Minor M","year":"2024","unstructured":"Minor M, Payne E. Herpes zoster ophthalmicus treasure island. (Florida): StatPearls; 2024."},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/82_2010_31"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.09.013"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.05.006"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2917"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1646129"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00180-9"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2010.0031"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01024-8"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab500"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.2.200"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1086\/421277"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir436"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3759-z"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066485"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(91)90189-D"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2021.01564"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3741"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa573"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir970"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-024-01126-0"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab387"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101923"},{"key":"e_1_3_7_70_1","unstructured":"GlaxoSmithKline [Internet]. SHINGRIX\u00ae (herpes zoster vaccine [recombinant adjuvanted]) SmPC. 2018 [cited 2024 Nov 5]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/shingrix-epar-product-information_en.pdf"},{"key":"e_1_3_7_71_1","unstructured":"Merck & Co. [Internet]. ZOSTAVAX\u00ae (zoster vaccine live) SmPC. 2022 [cited 2024 Nov 5. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zostavax-epar-product-information_en.pdf"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu918"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2263979"},{"key":"e_1_3_7_74_1","unstructured":"GlaxoSmithKline [Internet]. New long-term data show shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/new-long-term-data-show-shingrix-continues-to-provide-high-protection-against-shingles-in-adults-aged-50-and-over-for-more-than-a-decade\/"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2278362"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23-2023"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6227"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac170"},{"key":"e_1_3_7_79_1","unstructured":"U.S. Food and Drug Administration [Internet]. SHINGRIX (zoster vaccine recombinant adjuvanted) suspension for intramuscular injection - highlights of prescribing information; Available from: https:\/\/www.fda.gov\/media\/108597\/download?attachment"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac242"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac221"},{"issue":"4","key":"e_1_3_7_82_1","article-title":"Prevention of varicella; recommendations of the Advisory Committee on immunization practices (ACIP)","volume":"56","author":"Marin M","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, et al. Prevention of varicella; recommendations of the Advisory Committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007 June 22;56(RR\u20134).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_7_83_1","unstructured":"GOV.UK. JCVI statement on a childhood varicella (chickenpox) vaccination programme. 2023 [cited 2024 Nov 5]. Available from: https:\/\/www.gov.uk\/government\/publications\/childhood-varicella-vaccination-programme-jcvi-advice-14-november-2023\/jcvi-statement-on-a-childhood-varicella-chickenpox-vaccination-programme"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002233"},{"issue":"3","key":"e_1_3_7_85_1","first-page":"213","article-title":"Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs","volume":"68","author":"Gabutti G","year":"2016","unstructured":"Gabutti G, Franchi M, Maniscalco L, et al. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs. Minerva Pediatr. 2016;68(3):213\u2013225.","journal-title":"Minerva Pediatr"},{"key":"e_1_3_7_86_1","unstructured":"European Centre for Disease Prevention and Control [Internet]. Vaccine schedules in all countries of the European union. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/ecdc-vaccine-scheduler"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1825947"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1412620"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09837-9"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800004714"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091416"},{"issue":"25","key":"e_1_3_7_92_1","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"89","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265\u2013287.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282327"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-26"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1546525"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.026"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2005.04005.x"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126831"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac255"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00006"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw296"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125025"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.01.015"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1177\/25151355221084535"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy953"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1086\/430325"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz305"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34426"},{"key":"e_1_3_7_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-017-0782-z"},{"key":"e_1_3_7_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-021-04298-z"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-016-2475-8"},{"key":"e_1_3_7_112_1","unstructured":"World Health Organization [Internet]. Highlights from the meeting of the strategic Advisory group of experts (SAGE) on immunization 10\u201313. 2025Mar; [cited] Available from. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2025\/march\/sage_march_2025_highlights_final.pdf?sfvrsn=6ad38df_3"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7103a2"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_7_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1956906"},{"key":"e_1_3_7_116_1","unstructured":"UK Health Security Agency [Internet]. Vaccination against shingles guide. 2024 [cited 2024 Dec 6. https:\/\/www.gov.uk\/government\/publications\/shingles-vaccination-for-adults-aged-70-or-79-years-of-age-a5-leaflet\/vaccination-against-shingles-guide-from-september-2023"},{"key":"e_1_3_7_117_1","unstructured":"ATAGOI [Internet]. Statement on the clinical use of zoster vaccines in adults in Australia 2022 [cited 2024 Dec 6]. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2022\/05\/statement-on-the-clinical-use-of-zoster-vaccine-in-older-adults-in-australia.pdf"},{"key":"e_1_3_7_118_1","unstructured":"Prevention CfDCa [Internet]. Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on immunization practices \u2014 United States. 2022 [cited 2024 Dec 6]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7103a2.htm"},{"key":"e_1_3_7_119_1","unstructured":"University of Nebraska \u2013 Lincoln [Internet]. Public health resources. National and state-specific shingles vaccination among adults aged >60 years. 2017 [cited 2024 Nov 5]. Available from: https:\/\/core.ac.uk\/download\/pdf\/188111286.pdf"},{"key":"e_1_3_7_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09344-7"},{"key":"e_1_3_7_121_1","unstructured":"UK Health Security Agency [Internet]. Shingles vaccine coverage (England): report for quarter 1 of the financial year 2022 to 2023. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.gov.uk\/government\/publications\/herpes-zoster-shingles-immunisation-programme-2022-to-2023-evaluation-reports\/shingles-vaccine-coverage-england-report-for-quarter-1-of-the-financial-year-2022-to-2023#main-points"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.03.036"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2020.001"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.01.011"},{"key":"e_1_3_7_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30234-7"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.36160"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2168952"},{"key":"e_1_3_7_128_1","unstructured":"World Health Organization [Internet]. Principles and considerations for adding a vaccine to a national immunization programme. 2014 [cited 2024 Nov 5]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/111548\/9789241506892_eng.pdf?sequence=1"},{"key":"e_1_3_7_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.002"},{"key":"e_1_3_7_130_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2024-327700"},{"key":"e_1_3_7_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100544"},{"key":"e_1_3_7_132_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01145-2"},{"key":"e_1_3_7_133_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1708"},{"key":"e_1_3_7_134_1","doi-asserted-by":"publisher","DOI":"10.1080\/15265161.2020.1795528"},{"key":"e_1_3_7_135_1","unstructured":"Centers for Disease Control and Prevention [Internet]. Recommended child and adolescent immunization schedule for ages 18 years or younger. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf"},{"key":"e_1_3_7_136_1","unstructured":"Centers for Disease Control and Prevention [Internet]. Recommended adult immunization schedule for ages 19 years or older. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/downloads\/adult\/adult-combined-schedule.pdf"},{"key":"e_1_3_7_137_1","unstructured":"Government of Canada [Internet]. Recommended immunization schedules: Canadian immunization guide. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-1-key-immunization-information\/page-13-recommended-immunization-schedules.html#p1c12a2"},{"key":"e_1_3_7_138_1","unstructured":"Australian Government Department of Health and Aged Care [Internet]. National immunisation program schedule. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.health.gov.au\/resources\/publications\/national-immunisation-program-schedule?language=en"},{"key":"e_1_3_7_139_1","unstructured":"Federal Ministry of Health (Germany) [Internet]. Vaccinations. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.bundesgesundheitsministerium.de\/en\/topics\/vaccinations"},{"key":"e_1_3_7_140_1","unstructured":"Ministero della salute [Internet]. The immunisation schedule. 2024 [cited 2024 Nov 5]. Available from: https:\/\/www.salute.gov.it\/portale\/vaccinazioni\/dettaglioContenutiVaccinazioni.jsp?lingua=english&id=5501&area=vaccinazioni&menu=vuoto"},{"key":"e_1_3_7_141_1","unstructured":"World Health Organization [Internet]. Antimicrobial resistance. 2021 [cited 2024 Nov 5]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"e_1_3_7_142_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269916"},{"key":"e_1_3_7_143_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01393-5"},{"key":"e_1_3_7_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.03.351"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2514527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:44:08Z","timestamp":1765521848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2514527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2514527"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2514527","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}